The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis

Abstract Aims Venlafaxine is used to treat depression worldwide. Previous reviews have demonstrated that venlafaxine lowers scores on depression rating scales, producing statistically significant results but the relevance to patients remains uncertain. Knowledge of the incidence of the adverse effec...

Full description

Bibliographic Details

Published in:	Epidemiology and Psychiatric Sciences
Main Authors:	C. B. Kamp, J. J. Petersen, P. Faltermeier, S. Juul, F. Siddiqui, J. Moncrieff, M. A. Horowitz, M. P. Hengartner, I. Kirsch, C. Gluud, J. C. Jakobsen
Format:	Article
Language:	English
Published:	Cambridge University Press 2024-01-01
Subjects:	adverse effects antidepressants depression systematic reviews
Online Access:	https://www.cambridge.org/core/product/identifier/S2045796024000520/type/journal_article